We are live on ! Find out more

TRLV

Trulieve Cannabis Corp

TRLV

Market cap $2.18B

11.31 USD

-0.01

0.09%

At close Updated Sep 11, 4:00 PM EDT

Pre-market

After hours

11.18

-0.13

1.15%

1 day

-0.09%

5 days

-4.96%

1 month

21.61%

3 months

-2.08%

6 months

-1.65%

Year to date

-1.65%

1 year

-1.65%

5 years

-1.65%

10 years

-1.65%

About: Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.

Employees: 5,000

Healthcare Drug Manufacturers - Specialty & Generic

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 34.6%

Neutral 65.4%

Negative 0%

Trulieve: As Regulatory Headwinds Wane, Value Creation Is On The Cards

Trulieve Cannabis Corp. is reinitiated as a Buy, driven by regulatory catalysts and attractive valuation after a recent 81% rally. Rescheduling of medicinal cannabis to Schedule III eliminates punitive tax burdens, boosts cash flows, and enables greater R&D and financing flexibility for TRLV. TRLV is well-positioned for growth through Florida consolidation, expansion into Texas and Alabama, and potential upside from a $583M tax liability reversal.

Trulieve: As Regulatory Headwinds Wane, Value Creation Is On The Cards

MarijuanaStocks

Cannabis Stocks And Rescheduling: What Investors Should Watch In 2026

More than ever, federal cannabis reform is gaining momentum. With all the progress that has evolved since mid-2018, the future holds untapped potential. But the big issue remains: there is no true federal reform, even with the recent rescheduling of cannabis to a now class 3 subtance. For those invested in the sector, this regulatory progress could continue creating volatility across marijuana stocks and pot stocks. Schedule III treatment may eventually improve research opportunities and significantly change the tax environment for qualifying cannabis businesses.

Cannabis Stocks And Rescheduling: What Investors Should Watch In 2026

Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgia

New DeKalb County location will host grand opening celebration Thursday, September 10 TALLAHASSEE, Fla., Sept. 4, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Dunwoody, Georgia.

Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgia

Trulieve Announces September 2026 Event Participation

TALLAHASSEE, Fla., Sept. 2, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced planned event participation in September.

Trulieve Announces September 2026 Event Participation

MarijuanaStocks

3 Marijuana Stocks To Focus On For Future Growth And Profits

Marijuana stock investors are watching for new market potential. With all the new laws and changes, the possibilities to make money are there. Now, much of this sector has forever been one that is almost impossible to gauge. Meaning the volatility is so high that even the best company news may not impact trading like other public companies.

3 Marijuana Stocks To Focus On For Future Growth And Profits

Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSE

TALLAHASSEE, Fla., Aug. 18, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., announced it will ring The Closing Bell® at the New York Stock Exchange (NYSE) at 4:00 P.M.

Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSE

MarijuanaStocks

3 Marijuana Stocks For Investors To Consider

What will help marijuana stock investors trade more, even in the midst of laws changing in the USA? It is no secret that nothing has moved pot stocks more than news of global reform or regulatory matters. For the US, what happens at the federal level has moved the needle the most, with the recent passing of legislation to reclassify cannabis to Schedule 3.

3 Marijuana Stocks For Investors To Consider

Trulieve Completes Redomicile from British Columbia to Delaware

TALLAHASSEE, Fla., Aug. 11, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the completion of its previously announced plan to redomicile Trulieve Cannabis Corp. from British Columbia, Canada to Delaware, United States.

Trulieve Completes Redomicile from British Columbia to Delaware

Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buy

Trulieve Cannabis (TRLV) is the first U.S. cannabis operator to uplist to the NYSE, unlocking broader investor access and liquidity. Recent catalysts include a $50 million share repurchase program and a profitable Q1 2026 with $42 million in free cash flow. Reclassification of medical marijuana to Schedule III removes the 280E tax burden, providing a major earnings and cash flow tailwind for TRLV.

Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buy

Trulieve Cannabis Q2 Earnings Call Highlights

Trulieve Cannabis NYSE: TRLV reported second-quarter revenue of $271 million, while outlining plans to expand in Georgia and Texas following changes in medical cannabis regulations and the company's June listing on the New York Stock Exchange.

Trulieve Cannabis Q2 Earnings Call Highlights

See News Rankings

Price charts implemented using Lightweight Charts™